NYSE:BRSP Stock Quote
5.5500
-0.0100 (-0.18%)
Brightspire Capital Inc is a real estate investment trust (REIT) focused on acquiring, managing, and financing commercial real estate properties across the United States
The company seeks to generate attractive risk-adjusted returns for its shareholders through a diversified portfolio that includes a range of property types such as office buildings, industrial sites, and multifamily residences. Brightspire Capital leverages its expertise in real estate investment and management to identify opportunities in the market, aiming to enhance asset value while providing steady income streams. The firm employs a disciplined investment strategy and actively engages in asset management to navigate market dynamics effectively.

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via Benzinga · February 21, 2024

BRSP stock results show that BrightSpire Capital met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024

BRSP stock results show that BrightSpire Capital beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday.
Via Benzinga · March 27, 2024

Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why.
Via Benzinga · March 4, 2024

The latest data from the Mortgage Bankers Association (MBA) revealed a significant uptick in U.S. mortgage applications.
Via Benzinga · November 22, 2023

Via Benzinga · May 9, 2023

Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually the highest among the total REIT universe.
Via Benzinga · March 3, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via Benzinga · March 1, 2023

Via Benzinga · February 22, 2023

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via Benzinga · October 30, 2023

Via Benzinga · March 1, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via Benzinga · March 1, 2023

It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via InvestorPlace · March 1, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via Benzinga · March 1, 2023

The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries. Mortgage REITs allow investors to join the real estate market without owning the physical property.
Via Benzinga · November 19, 2022

Via Benzinga · December 6, 2022

BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital reported in-line EPS of $0.25 versus an estimate of $0.25.
Via Benzinga · November 2, 2022

BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via Benzinga · August 3, 2022